Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1318 clinical trials
Featured trial
CardioMEMSTM HF System Post Approval Study

CardioMEMSTM HF System Post Approval Study

  • 522 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Do you think you're having difficulty controlling your high blood pressure?

Do you think you're having difficulty controlling your high blood pressure?

  • 467 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

  • 163 views
  • 08 Dec, 2020
  • 1 location
Featured trial
Do you suffer from Hemorrhoids?

Do you suffer from Hemorrhoids?

  • 1549 views
  • 25 Mar, 2021
  • 1 location
Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure (HSS)

Acute decompensated heart failure (HF) is one of the most common cardiologic issues in emergency departments. Loop diuretics have long been recognized as the key for the treatment of

  • 0 views
  • 18 Apr, 2022
  • 1 location
Sacubitril/Valsartan for CKD5 Stage Dialysis Patients With Heart Failure

Hemodialysis or peritoneal dialysis CKD5 patients with heart failure were randomly divided into Sacubitril/Valsartan and irbesartan treatment groups. Comparing the survival rates, the cardiac

  • 0 views
  • 12 Mar, 2022
Effect of the MobiusHD® in Patients With Heart Failure (HF-FIM)

This is a prospective, multi-center, open-label clinical trial intended to evaluate the safety and effectiveness of the MobiusHD® in patients with heart failure and reduced ejection fraction.

  • 0 views
  • 13 May, 2022
  • 7 locations
ContraBand™: FIH Safety & Feasibility Study (RM-20-01)

The ContraBand™ device is intended for treatment of heart failure patients who remain symptomatic despite the use of optimally tolerated guideline directed medical therapy. ContraBand™ is a

medical therapy
systolic heart failure
  • 0 views
  • 21 Mar, 2022
  • 4 locations
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.

The purpose of this study is to evaluate efficacy of rhNRG-1 in reducing the death rate of heart failure subjects with baseline NT-proBNP level between 600 pg/ml and 1700 pg/mL and NYHA class II

ejection fraction
nt-probnp
systolic heart failure
  • 43 views
  • 04 Mar, 2022
  • 64 locations
"HerzCheck" - Detection of Early Heart Failure Using Telemedicine in Structurally Weak Regions

This study is intended to provide a basis for decision-making for the improved medical care of patients with asymptomatic heart failure, especially in structurally weak regions.

  • 0 views
  • 08 Dec, 2021
  • 1 location